GERN Stock Summary and Trading Ideas (Geron | NASDAQ:GERN)

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.

What symbol and exchange does Geron shares trade?

Geron trades on the NASDAQ stock market under the symbol GERN.

What is Geron stock price doing today?

As of August 11, 2026, GERN stock price climbed to $1.63 with 12,500,171 million shares trading.

What is Geron's Beta?

GERN has a beta of 1.46, meaning it tends to be more sensitive to market movements. GERN has a correlation of 0.11 to the broad based SPY ETF.

How much is Geron worth?

GERN has a market cap of $1.05 billion. This is considered a Small Cap stock.

How much money does Geron make?

Last quarter Geron reported $57 million in Revenue and -$.02 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.01.

What is the highest and lowest price Geron traded in the last 3 year period?

In the last 3 years, GERN traded as high as $5.34 and as low as $1.04.

What are the top ETFs holding Geron?

The top ETF exchange traded funds that GERN belongs to (by Net Assets): XBI, VTI, IWM, VXF, IWO.

Is Geron (GERN) a good investment?

GERN has underperformed the market in the last year with a return of +19.9%, while SPY returned +22.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in GERN shares. However, GERN has outperformed the market in the last 3 month and 2 week periods, returning +17.3% and +12.4%, while SPY returned +4.5% and +4.0%, respectively. This indicates GERN has been having a stronger performance recently.

What are the support and resistance levels for Geron (GERN)?

GERN support price is $1.41 and resistance is $1.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GERN shares will trade within this expected range on the day.